CAS: 413589-34-1; Magnesium,1-Chloro-2-Fluorobenzene-5-Ide,Bromide

该化合物是属于Grignard试剂类的有机磁性化合物.该化合物通常具有与溴替代品芳香环捆绑在一起的镁原子特性,在此情况下,它包括氯和氟替代元素.这些卤素的存在可以影响化合物的再活性和稳定性,使其在各种合成应用中有用,特别是在有机合成中. Grignard 试剂因其核循环特性而著称,允许它们与电极反应形成碳结.苯基环上的卤素的具体安排可能会影响电子特性和阻力,而这反过来又会影响化合物在联动反应或其他变异作用中的再活性.与许多有机金属化合物一样,在处理溴(3-氯-4-氟联苯)磁性时必须小心谨慎,因为它可能具有高度反应性,尤其是与湿气和推进溶剂.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

1-bromo-3-chloro-4-fluorobenzene

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-8487108-B2
    优先权日:2005-11-14
    标题 :Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors
    发明人:BALDWIN JOHN J; CLAREMON DAVID A; TICE COLIN; CACATIAN SALVACION; DILLARD LAWRENCE W; ISHCHENKO ALEXEY V; YUAN JING; XU ZHENRONG; MCGEEHAN GERARD; SIMPSON ROBERT D; SINGH SURESH B; ZHAO WEI; FLAHERTY PATRICK T
    权利人:BALDWIN JOHN J; CLAREMON DAVID A; TICE COLIN; CACATIAN SALVACION; DILLARD LAWRENCE W; ISHCHENKO ALEXEY V; YUAN JING; XU ZHENRONG; MCGEEHAN GERARD; SIMPSON ROBERT D; SINGH SURESH B; ZHAO WEI; FLAHERTY PATRICK T; VITAE PHARMACEUTICALS INC
    摘要:The present invention is directed to aspartic protease inhibitors. Certain aspartic protease inhibitors of the invention can be represented by the following structural formula or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Selt, M.; Waldvogel, S. R., Science of Synthesis: Special Topics, (2021) 1, 269.
    摘要:Adak, L.; Sahoo, S.; Aoki, S.; Kawanaka, Y.; Nakamura, M., Science of Synthesis: Base-Metal Catalysis, (2023) 2, 407.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知